World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 8 May 2017
Main ID:  ISRCTN84990302
Date of registration: 12/05/2010
Prospective Registration: No
Primary sponsor: Cambridgeshire and Peterborough NHS Foundation Trust (UK)
Public title: Cortisol reactivity as a biomarker for depression
Scientific title: Cortisol hyper-reactivity to stress - a putative biomarker for major depressive disorder
Date of first enrolment: 13/04/2010
Target sample size: 228
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN84990302
Study type:  Observational
Study design:  Single-centre screening clinical laboratory study (Screening)  
Phase:  Not Applicable
Countries of recruitment
United Kingdom
Contacts
Name: Paul    Wilkinson
Address:  Developmental Psychiatry Section University of Cambridge Douglas House 18b Trumpington Road CB2 8AH Cambridge United Kingdom
Telephone:
Email:
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Aged 16 - 21 years old
2. Male and female
3. Recruited from Roots study

Exclusion criteria: 1. Take regular steroid medication (oral or inhaled) or take hormonal contraceptives containing oestrogens (combined pill, injection, implant or patch)
2. Hypertension requiring regular treatment
3. Systolic blood pressure above 140 mmHg or resting pulse over 100 mmHg at the start of the study
4. Current respiratory disease, e.g., asthma
5. A personal or family history (parent or sibling) of panic disorder
6. Significant claustrophobia
7. Smoke daily; no smoking on day of assessment
8. Migraine within the last year
9. Current heart disease
10. Females will be excluded if they are or think they might be pregnant, are lactating, or their menstrual cycle has not returned to being regular after pregnancy
11. At least one biological grandparent known to be non-white European
12. At least one of the following psychiatric disorders at time of interview: anxiety disorder, OCD, oppositional defiant disorder, PTSD, conduct disorder, bipolar disorder
13. Alcohol or illicit drug use on the day of or the day before research assessment
14. Caffeine use since breakfast on the day of research assessment
15. Consume large amounts of caffeinated drinks on a regular basis (greater than six cups of coffee per day or drinks containing methylxanthines such as Pepsi or red bull)
16. Current severe cold or flu
17. Vigorous exercise for 2 hours before testing

Additional group-specific criteria:
18. Never-depressed participants:
18.1. No lifetime history of major depressive disorder
18.2. No lifetime history of at least one of the following psychiatric disorders: anxiety disorder, OCD, oppositional defiant disorder, PTSD, conduct disorder, bipolar disorder, ADHD
19. Recovered-depressed:
19.1. At least one past episode of major depressive disorder
19.2. At least 8 weeks of having fewer than two depressive symptoms since last episode
19.3. Not currently taking antidepressants
19.4. No lifetime history of ADHD, autism, conduct disorder with onset before age 11


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Topic: Mental Health Research Network; Subtopic: Depression, Stress-related and somatoform; Disease: Depression, Stress-related and somatoform disorders
Mental and Behavioural Disorders
Depressive episode
Intervention(s)
35% Carbon Dioxide Vital Capacity Inhalation Stress Test:
Participants insert the mouthpiece into their mouth. The three-way valve is set so they are breathing air. The experimenter asks the participant to breathe fully out, then take a breath as deep as they can, and hold it for 4 seconds, as a practice. The valve is changed so the CO2 tank is connected to the bag reservoir. The reservoir is filled. The valve is changed so the mouthpiece is attached to the CO2 in the reservoir. The participant breathes in and holds as with the practice.

Trier Social Stress Test:
The experimenter leads the participant to the experimental room at time 0, where they are introduced to two people (the 'committee'), a microphone and a video-camera. The experimenter tells the participant that they will have to deliver a speech for a job application to the committee, followed by another task, that will be detailed then. They are given instructions by the committee, then prepare their speech until T +3 min. They are asked to deliver the speech. If they stop before 5 minutes, or their speech is not relevant, there are standard questions and prompts. Then they are asked to do the second task, where they must serially subtract 13 from 1022 as quickly and accurately as possible. After mistakes, they are asked return to 1022 and re-start. This lasts 5 minutes, then the task ends.

Each test happens once, and follow-up is for 60 minutes after start of test.
Primary Outcome(s)
Salivary cortisol area under the curve in the time period after intervention, collected 20 minutes before and immediately before, and 20, 30, 40 and 60 minutes after, the onset of each stress test.
Secondary Outcome(s)
1. Performance on affective go:no go, measured at rest (before first stress test) and 30 minutes after the start of each stress test
2. Ratio of negative to positive words correctly recalled, measured at rest (before first stress test) and 25 minutes after the start of each stress test
3. Which stress test leads to largest rise in cortisol?
Secondary ID(s)
7554; G0801443
Source(s) of Monetary Support
Medical Research Council (MRC) (UK) (ref: G0801443)
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history